Analysts Offer Predictions for MGRM Q3 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Analysts at Zacks Small Cap issued their Q3 2025 EPS estimates for shares of Monogram Orthopaedics in a report released on Thursday, March 13th. Zacks Small Cap analyst T. Kerr expects that the company will post earnings of ($0.11) per share for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share.

Monogram Orthopaedics (NASDAQ:MGRM) last posted its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03.

Several other brokerages have also recently weighed in on MGRM. Roth Mkm began coverage on Monogram Orthopaedics in a research note on Monday, December 9th. They set a “buy” rating and a $4.00 target price for the company. Roth Capital raised shares of Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

Monogram Orthopaedics Stock Performance

Shares of MGRM stock opened at $2.33 on Friday. Monogram Orthopaedics has a 1 year low of $1.53 and a 1 year high of $4.90. The business’s fifty day moving average is $2.54 and its 200-day moving average is $2.49. The stock has a market cap of $79.95 million, a PE ratio of -4.96 and a beta of 1.66.

Institutional Investors Weigh In On Monogram Orthopaedics

Institutional investors and hedge funds have recently modified their holdings of the stock. Commonwealth Equity Services LLC grew its holdings in shares of Monogram Orthopaedics by 21.5% in the 4th quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company’s stock worth $99,000 after acquiring an additional 7,366 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Monogram Orthopaedics by 286.6% during the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock valued at $27,000 after purchasing an additional 8,597 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of Monogram Orthopaedics in the 4th quarter valued at $25,000. Barclays PLC purchased a new position in Monogram Orthopaedics in the 3rd quarter worth about $29,000. Finally, Orion Portfolio Solutions LLC acquired a new stake in Monogram Orthopaedics during the 4th quarter worth about $31,000. Institutional investors and hedge funds own 0.45% of the company’s stock.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.